HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Ahn, J. Y. Articles by Jang, K. L. Search for Related Content PubMed PubMed Citation Articles by Ahn, J. Y. Articles by Jang, K. L. Agricola Articles by Ahn, J. Y. Articles by Jang, K. L.

Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53

Department of Microbiology, College of Natural Sciences, Pusan National University, Pusan 609-735, Korea¹
Department of Life Science, Pohang University of Science and Technology, Pohang 790-784, Korea²

Author for correspondence: Kyung Lib Jang. Fax +82 51 514 1778. e-mail kljang{at}pusan.ac.kr

Despite the extensive studies on the roles of hepatitis B virus (HBV) X protein (HBx) in the development of hepatocellular carcinomas (HCCs), the mechanisms by which HBx contributes to HCC remain controversial. In this study, the effect of HBx on the G₁–S checkpoint control depending on the status of p53 was compared. Transcription of p21^waf1/cip1 was activated by HBx in the presence of functional p53 in a dose-dependent manner. However, it was repressed by HBx when p53 was absent or present at a low level. Furthermore, the growth rate of the HBx-expressing NIH3T3 cell lines compared with that of the parental cells was decreased when p53 was upregulated by a DNA-damaging agent, cisplatin, whereas it increased approximately twofold when p53 was present at a very low level. Thus, the opposite effects of HBx on the regulation of the cell cycle depending on the status of p53 might be important to understand the progression of hepatic diseases in HBV-positive patients.

This article has been cited by other articles:

				J. K. Jung, H. J. Kwun, J.-O. Lee, P. Arora, and K. L. Jang Hepatitis B virus X protein differentially affects the ubiquitin-mediated proteasomal degradation of beta-catenin depending on the status of cellular p53 J. Gen. Virol., August 1, 2007; 88(8): 2144 - 2154. [Abstract] [Full Text] [PDF]

				M. J. Bouchard and R. J. Schneider The Enigmatic X Gene of Hepatitis B Virus J. Virol., December 1, 2004; 78(23): 12725 - 12734. [Full Text] [PDF]

				H. J. Kwun and K. L. Jang Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene Nucleic Acids Res., April 23, 2004; 32(7): 2202 - 2213. [Abstract] [Full Text] [PDF]